title: Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.
abstract: The delivery of viral vectors to the brain for treatment of intracerebral tumors is most commonly accomplished by stereotaxic inoculation directly into the tumor. However, the small volume of distribution by inoculation may limit the efficacy of viral therapy of large or disseminated tumors. We have investigated mechanisms to increase vector delivery to intracerebral xenografts of human LX-1 small-cell lung carcinoma tumors in the nude rat. The distribution of Escherichia coli lacZ transgene expression from primary viral infection was assessed after delivery of recombinant virus by intratumor inoculation or intracarotid infusion with or without osmotic disruption of the blood-brain barrier (BBB). These studies used replication-compromised herpes simplex virus type 1 (HSV; vector RH105) and replication-defective adenovirus (AdRSVlacZ), which represent two of the most commonly proposed viral vectors for tumor therapy. Transvascular delivery of both viruses to intracerebral tumor was demonstrated when administered intraarterially (i.a.) after osmotic BBB disruption (n = 9 for adenovirus; n = 7 for HSV), while no virus infection was apparent after i.a. administration without BBB modification (n = 8 for adenovirus; n = 4 for HSV). The thymidine kinase-negative HSV vector infected clumps of tumor cells as a result of its ability to replicate selectively in dividing cells. Osmotic BBB disruption in combination with i.a. administration of viral vectors may offer a method of global delivery to treat disseminated brain tumors.
authors.affiliation: Department of Neurology, Oregon Health Sciences University, Portland 97201, USA.
authors.forename: G
authors.initials: G
authors.lastname: Nilaver
authors.forename: L L
authors.initials: LL
authors.lastname: Muldoon
authors.forename: R A
authors.initials: RA
authors.lastname: Kroll
authors.forename: M A
authors.initials: MA
authors.lastname: Pagel
authors.forename: X O
authors.initials: XO
authors.lastname: Breakefield
authors.forename: B L
authors.initials: BL
authors.lastname: Davidson
authors.forename: E A
authors.initials: EA
authors.lastname: Neuwelt
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D030801:Animals, Genetically Modified; D001812:Blood-Brain Barrier; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000628:therapy / Q000821:virology*; D018288:Carcinoma, Small Cell / Q000821:virology; D005260:Female; D018014:Gene Transfer Techniques / Q000401:mortality; D015316:Genetic Therapy; D005822:Genetic Vectors; D006564:Herpesviridae / Q000235:genetics*; D006801:Humans; D007763:Lac Operon; D008175:Lung Neoplasms / Q000821:virology; D009368:Neoplasm Transplantation; D051381:Rats; D011923:Rats, Nude; D014779:Virus Replication